• Agatoxin-Sensitive Calcium Channels in Vagal Neurons

  2026-09-13

  Wang, Irnaten, and Mendelowitz used whole-cell patch clamp recordings to show that agatoxin-IVA-sensitive voltage-dependent calcium channels link nicotinic receptor activation to both direct excitation and enhanced glutamatergic transmission in cardiac vagal neurons. The study distinguishes a P-type-sensitive mechanism shared by presynaptic and postsynaptic responses from an additional L-type contribution to synaptic facilitation.

• EDC.HCl: Practical Coupling Workflow Guide

  2026-09-12

  EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis, bioconjugation, and related in vitro workflows. It should be handled as a research reagent only; the product dossier reports no in vivo or clinical data, and freshly prepared solutions are preferred over long-term storage.

• Biotin-HPDP: Reversible Thiol Labeling

  2026-09-11

  A practical, scenario-driven guide to using Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide), SKU A8008, for reversible thiol-specific protein labeling and downstream streptavidin detection. It connects reagent chemistry with controls, solvent handling, affinity purification, S-nitrosylation workflows, and interpretation of cell-based assay results.

• Extracellular Vesicle ACLY Drives HCC TAMs

  2026-09-11

  The reference study identifies extracellular vesicle-transferred ATP-citrate lyase (ACLY) as a metabolic signal that directs monocytes toward immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. Its engineered CD81-decorated vesicles provide a causal delivery model and suggest that TAM-specific ACLY inhibition may improve anti-PD-1/PD-L1 responses.

• L-Ornithine B8919 for Reliable Cell Assays

  2026-09-10

  A scenario-driven guide to using L-Ornithine (SKU B8919) in cell viability, proliferation, cytotoxicity, and amino acid metabolism research. It connects formulation, solubility, protocol controls, vendor evaluation, and recent liver–brain-axis evidence to improve experimental interpretability.

• c-Myc Tag Peptide: From Assay Control to Translation

  2026-09-10

  A mechanistic and strategic guide to using c-Myc Peptide as a defined competition reagent for immunoassays, while connecting c-Myc biology, transcription factor regulation, and translational assay design.

• EdU as a Translational Lens on CRC Metabolism

  2026-09-09

  The serine/glycine-free diet study reveals a translational paradox in colorectal cancer: metabolic restriction can enhance cytotoxic immunity while also stabilizing PD-L1 through lactylation. This article explains how EdU-based flow cytometry can separate tumor-cell DNA synthesis from immune-cell proliferation, strengthening pharmacodynamic and mechanistic studies built around that finding.

• Estradiol Benzoate: An Assay-Design Framework

  2026-09-09

  Estradiol Benzoate can do more than activate ERα: it can anchor a tiered strategy for separating receptor binding, transcriptional response, and formulation artifacts. This guide translates computational-screening lessons into more rigorous estrogen receptor signaling research.

• Dinaciclib Selectivity in VHL-Deficient Renal Cancer

  2026-09-08

  Nelson and colleagues identify a preclinical synthetic-lethal relationship between Dinaciclib treatment and VHL deficiency in clear cell renal cell carcinoma. Their combination of cell-based assays, pathway analysis, VHL re-expression, and an orthotopic patient-derived xenograft model supports selective targeting of both tumor cells and CD105-defined cancer stem-cell populations, while also highlighting important translational limitations.

• Purmorphamine: Smoothened Agonist Workflows

  2026-09-08

  Purmorphamine is a practical Smoothened agonist for connecting Hedgehog pathway activation with osteogenic, receptor-level, and sensory readouts. This guide translates product specifications and honeybee Smo findings into dose-aware workflows, controls, and troubleshooting strategies for bone regeneration research and beyond.

• Self-Assembling EVMPs for Extrahepatic mRNA Delivery

  2026-09-07

  Yu and colleagues developed a bottom-up enveloped virus-mimicking particle (EVMP) that combines a self-assembling virus-mimicking peptide with programmable phospholipid envelopes for extrahepatic mRNA delivery. The platform achieved substantial lung-cell transfection and produced antitumor activity when loaded with IL-12 mRNA, while its modular design addresses important limitations of viral vectors and conventional liver-biased nanoparticles.

• Pyridostigmine Targets Placental Necroptosis in PE

  2026-09-07

  The reference study identifies placental necroptosis as a pharmacologically tractable component of preeclampsia-like pathology in rats. Its experiments link pyridostigmine-enhanced non-neuronal cholinergic signaling to α7 nicotinic acetylcholine receptor activity, reduced inflammation and oxidative stress, and improved trophoblast behavior.

• Nullscript: Translational Logic for HDAC Inhibition

  2026-09-05

  Nullscript offers a useful way to separate HDAC inhibition from transcriptional facilitation in translational research. This article connects its cardiac ischemia/reperfusion evidence with the mechanistic discipline demonstrated by recent RIPK3-necroptosis research, while defining practical limits for cardiovascular, neurodegeneration, and oncology studies.

• Bacterial HTS for Pharmacological Chaperones in AKU

  2026-09-04

  A 2025 European Journal of Pharmacology study developed a bacterial high-throughput assay to identify compounds that restore activity to missense variants of human homogentisate 1,2-dioxygenase in alkaptonuria. Screening 2,320 approved drugs produced 30 hits for the HGDG161R variant, while docking and dose-response data prioritized one compound for further investigation.

• Apicidin: HDAC Mechanism to Translational Strategy

  2026-09-04

  Apicidin is a selective histone deacetylase inhibitor whose value extends from cancer biology and angiogenesis research to emerging reproductive toxicology. This thought-leadership analysis connects HDAC3/HDAC6 pharmacology with assay design, translational decision-making, and the limits of interpreting preclinical efficacy.

8113 records 1/541 page Next 12345 下5页 Last page